BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Advarra - ECPv6.15.12.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Advarra
X-ORIGINAL-URL:https://www.advarra.com
X-WR-CALDESC:Events for Advarra
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260512T110000
DTEND;TZID=America/New_York:20260512T120000
DTSTAMP:20260615T061747
CREATED:20260420T204210Z
LAST-MODIFIED:20260501T220315Z
UID:69507-1778583600-1778587200@www.advarra.com
SUMMARY:Webinar - AMRC The Network Advantage: Three models\, one goal. Scaling site success
DESCRIPTION:Webinar – AMRC The Network Advantage: Three models\, one goal. Scaling site success\n\n\n\n\n\nJoin us for an in-depth conversation on effective strategies for growing your site within today’s evolving clinical research landscape. Hear from subject matter experts representing 3 leading site networks as they share proven approaches to expanding site business by leveraging multi-site network models.
URL:https://www.advarra.com/event/webinar-amrc-the-network-advantage-three-models-one-goal-scaling-site-success/
CATEGORIES:Virtual,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260519T130000
DTEND;TZID=America/New_York:20260519T133000
DTSTAMP:20260615T061747
CREATED:20260415T171615Z
LAST-MODIFIED:20260415T175939Z
UID:69404-1779195600-1779197400@www.advarra.com
SUMMARY:Launching Advarra Voice to the Site Community
DESCRIPTION:Launching Advarra Voice to the Site Community\n\n\n\n\n\n\n\n\nHelp Shape the Future of Product InnovationAdvarra’s customers shape our product innovation. This webinar introduces Advarra Voice—a new\, interactive voting experience designed to give you another way to influence product development.Advarra Voice is built for all Advarra customers\, but this exclusive webinar is for OnCore and Clinical Conductor administrators and users.In this webinar\, you’ll:• see the Advarra Voice experience in action• preview upcoming CTMS and site technology innovations• vote on the features and enhancements that matter mostBy capturing your feedback\, Advarra Voice helps ensure Advarra’s solutions better meet your needs.Join us to provide your feedback on Advarra’s roadmap so that it delivers meaningful value to you and your organization. \n\n\n\nSpeaker:\n\n\n\nJames WurdemanSVP Product Lead – Research Site Solutions\, AdvarraJames Wurdeman is the Senior Vice President of Product Lead forResearch Site Solutions at Advarra. In this role\, he collaborates with Advarra’s research community to understand their challenges and translates those challenges into solution-based enhancements to our product offerings. His 17 years’ experience leading customer support and product management functions ensures Advarra can advance and optimize the day-to-day workflows of clinical research.
URL:https://www.advarra.com/event/launching-advarra-voice-to-the-site-community/
CATEGORIES:Virtual,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260527T130000
DTEND;TZID=America/New_York:20260527T140000
DTSTAMP:20260615T061747
CREATED:20260514T171208Z
LAST-MODIFIED:20260514T171216Z
UID:69905-1779886800-1779890400@www.advarra.com
SUMMARY:Federal Public Policy Briefing: Understanding 21 CFR 50.54: When FDA-Regulated Pediatric Research Requires Federal Review
DESCRIPTION:Federal Public Policy Briefing: Understanding 21 CFR 50.54: When FDA-Regulated Pediatric Research Requires Federal Review\n\n\n\n\n\nResearch involving children that poses more than minor increase over minimal risk without direct benefit requires federal review under 21 CFR 50.54/46.407\, yet sponsors\, investigators\, and IRBs frequently hesitate to pursue this pathway. This session examines why that hesitancy persists\, the regulatory challenges it creates\, and how stakeholders can better navigate federal referral to advance pediatric research while maintaining participant protections. \n\n\n\n\nRegister now
URL:https://www.advarra.com/event/federal-public-policy-briefing-understanding-21-cfr-50-54/
CATEGORIES:Third-Party Webinars,Virtual,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260528T110000
DTEND;TZID=America/New_York:20260528T120000
DTSTAMP:20260615T061747
CREATED:20260506T225713Z
LAST-MODIFIED:20260506T225852Z
UID:69850-1779966000-1779969600@www.advarra.com
SUMMARY:Ensuring Operational Feasibility in Next-Generation Oncology Trials
DESCRIPTION:Ensuring Operational Feasibility in Next-Generation Oncology Trials\n\n\n\n\n\nRapid advances in oncology such as cell therapies\, antibody-drug conjugates\, biomarker-driven treatments\, and increasingly adaptive trial designs (including basket\, umbrella\, and platform studies) are transforming how cancer drugs are developed. While these breakthroughs hold enormous promise\, they also introduce new operational challenges related to patient identification\, evolving protocols\, specialized sites\, complex logistics\, and trial execution across multiple cohorts and arms. \n\n\n\n\nRegister now
URL:https://www.advarra.com/event/ensuring-operational-feasibility-in-next-generation-oncology-trials/
CATEGORIES:Webinar
END:VEVENT
END:VCALENDAR